Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study
Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after...
Gespeichert in:
Veröffentlicht in: | Neuropsychopharmacology (New York, N.Y.) N.Y.), 2019-09, Vol.44 (10), p.1720-1727 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1727 |
---|---|
container_issue | 10 |
container_start_page | 1720 |
container_title | Neuropsychopharmacology (New York, N.Y.) |
container_volume | 44 |
creator | Martinez, Diana Slifstein, Mark Matuskey, David Nabulsi, Nabeel Zheng, Ming-Qiang Lin, Shu-Fei Ropchan, Jim Urban, Nina Grassetti, Alexander Chang, Dinnisa Salling, Michael Foltin, Richard Carson, Richard E Huang, Yiyun |
description | Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [
C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [
C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [
C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [
C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder. |
doi_str_mv | 10.1038/s41386-019-0398-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6785004</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2272719448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</originalsourceid><addsrcrecordid>eNpVkUFLXDEQx0NR6nbrB-ilBLyamkmySV4PBZFWiwteLHgy5CV5bsRN0uRtYb-9b1krehqY-c9vBn4IfQH6DSjXZ00A15JQ6AjlnSbiA5qBEpRILu4O0IzqjhPg_O4IfWrtkVJYKKk_oiMOlEkt2QzdX9tSLMkl5uhxDS6UMdd2iv025VpWMZ1imzx22dmYArbeRzfGnL5ji0tucaw54bCOrU1NPOZ1fqi2rLa4jRu__YwOB_vUwvFLnaM_v37eXlyR5c3l74vzJXGCqZEAHYTUvl_wDqQKXtDANWO9FoPzvBeWaZCDdsBYUEwK5oaeew8eLOfdQvE5-rHnlk2_Dt6FNFb7ZEqNa1u3Jtto3k9SXJmH_M9IpReUiglw8gKo-e8mtNE85k1N08-GMcUUdELoKQX7lKu5tRqG1wtAzU6J2SsxkxKzU2J25K9vX3vd-O-APwNp6Ikn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2272719448</pqid></control><display><type>article</type><title>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Martinez, Diana ; Slifstein, Mark ; Matuskey, David ; Nabulsi, Nabeel ; Zheng, Ming-Qiang ; Lin, Shu-Fei ; Ropchan, Jim ; Urban, Nina ; Grassetti, Alexander ; Chang, Dinnisa ; Salling, Michael ; Foltin, Richard ; Carson, Richard E ; Huang, Yiyun</creator><creatorcontrib>Martinez, Diana ; Slifstein, Mark ; Matuskey, David ; Nabulsi, Nabeel ; Zheng, Ming-Qiang ; Lin, Shu-Fei ; Ropchan, Jim ; Urban, Nina ; Grassetti, Alexander ; Chang, Dinnisa ; Salling, Michael ; Foltin, Richard ; Carson, Richard E ; Huang, Yiyun</creatorcontrib><description>Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [
C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [
C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [
C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [
C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/s41386-019-0398-4</identifier><identifier>PMID: 31026862</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Addictions ; Adult ; Availability ; Brain ; Brain - diagnostic imaging ; Brain - metabolism ; Carbon Radioisotopes ; Case-Control Studies ; Choice Behavior ; Cocaine ; Cocaine - administration & dosage ; Cocaine Smoking ; Cocaine-Related Disorders - diagnostic imaging ; Cocaine-Related Disorders - metabolism ; Cocaine-Related Disorders - psychology ; Drug abuse ; Drug self-administration ; Drug therapy ; Dynorphin ; Dynorphins - metabolism ; Emission analysis ; Humans ; Laboratories ; Male ; Middle Aged ; Naltrexone - pharmacology ; Narcotic Antagonists - pharmacology ; Narcotics ; Neostriatum ; Neostriatum - diagnostic imaging ; Neostriatum - metabolism ; Neuroimaging ; Opioid receptors (type kappa) ; Piperazines ; Positron emission tomography ; Pyrrolidines ; Receptors, Opioid, kappa - metabolism ; Stress ; Stress, Psychological - psychology ; Tomography</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2019-09, Vol.44 (10), p.1720-1727</ispartof><rights>American College of Neuropsychopharmacology 2019.</rights><rights>American College of Neuropsychopharmacology 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</citedby><cites>FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785004/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785004/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31026862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinez, Diana</creatorcontrib><creatorcontrib>Slifstein, Mark</creatorcontrib><creatorcontrib>Matuskey, David</creatorcontrib><creatorcontrib>Nabulsi, Nabeel</creatorcontrib><creatorcontrib>Zheng, Ming-Qiang</creatorcontrib><creatorcontrib>Lin, Shu-Fei</creatorcontrib><creatorcontrib>Ropchan, Jim</creatorcontrib><creatorcontrib>Urban, Nina</creatorcontrib><creatorcontrib>Grassetti, Alexander</creatorcontrib><creatorcontrib>Chang, Dinnisa</creatorcontrib><creatorcontrib>Salling, Michael</creatorcontrib><creatorcontrib>Foltin, Richard</creatorcontrib><creatorcontrib>Carson, Richard E</creatorcontrib><creatorcontrib>Huang, Yiyun</creatorcontrib><title>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [
C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [
C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [
C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [
C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.</description><subject>Addictions</subject><subject>Adult</subject><subject>Availability</subject><subject>Brain</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Carbon Radioisotopes</subject><subject>Case-Control Studies</subject><subject>Choice Behavior</subject><subject>Cocaine</subject><subject>Cocaine - administration & dosage</subject><subject>Cocaine Smoking</subject><subject>Cocaine-Related Disorders - diagnostic imaging</subject><subject>Cocaine-Related Disorders - metabolism</subject><subject>Cocaine-Related Disorders - psychology</subject><subject>Drug abuse</subject><subject>Drug self-administration</subject><subject>Drug therapy</subject><subject>Dynorphin</subject><subject>Dynorphins - metabolism</subject><subject>Emission analysis</subject><subject>Humans</subject><subject>Laboratories</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Naltrexone - pharmacology</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Narcotics</subject><subject>Neostriatum</subject><subject>Neostriatum - diagnostic imaging</subject><subject>Neostriatum - metabolism</subject><subject>Neuroimaging</subject><subject>Opioid receptors (type kappa)</subject><subject>Piperazines</subject><subject>Positron emission tomography</subject><subject>Pyrrolidines</subject><subject>Receptors, Opioid, kappa - metabolism</subject><subject>Stress</subject><subject>Stress, Psychological - psychology</subject><subject>Tomography</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpVkUFLXDEQx0NR6nbrB-ilBLyamkmySV4PBZFWiwteLHgy5CV5bsRN0uRtYb-9b1krehqY-c9vBn4IfQH6DSjXZ00A15JQ6AjlnSbiA5qBEpRILu4O0IzqjhPg_O4IfWrtkVJYKKk_oiMOlEkt2QzdX9tSLMkl5uhxDS6UMdd2iv025VpWMZ1imzx22dmYArbeRzfGnL5ji0tucaw54bCOrU1NPOZ1fqi2rLa4jRu__YwOB_vUwvFLnaM_v37eXlyR5c3l74vzJXGCqZEAHYTUvl_wDqQKXtDANWO9FoPzvBeWaZCDdsBYUEwK5oaeew8eLOfdQvE5-rHnlk2_Dt6FNFb7ZEqNa1u3Jtto3k9SXJmH_M9IpReUiglw8gKo-e8mtNE85k1N08-GMcUUdELoKQX7lKu5tRqG1wtAzU6J2SsxkxKzU2J25K9vX3vd-O-APwNp6Ikn</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Martinez, Diana</creator><creator>Slifstein, Mark</creator><creator>Matuskey, David</creator><creator>Nabulsi, Nabeel</creator><creator>Zheng, Ming-Qiang</creator><creator>Lin, Shu-Fei</creator><creator>Ropchan, Jim</creator><creator>Urban, Nina</creator><creator>Grassetti, Alexander</creator><creator>Chang, Dinnisa</creator><creator>Salling, Michael</creator><creator>Foltin, Richard</creator><creator>Carson, Richard E</creator><creator>Huang, Yiyun</creator><general>Nature Publishing Group</general><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20190901</creationdate><title>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</title><author>Martinez, Diana ; Slifstein, Mark ; Matuskey, David ; Nabulsi, Nabeel ; Zheng, Ming-Qiang ; Lin, Shu-Fei ; Ropchan, Jim ; Urban, Nina ; Grassetti, Alexander ; Chang, Dinnisa ; Salling, Michael ; Foltin, Richard ; Carson, Richard E ; Huang, Yiyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Addictions</topic><topic>Adult</topic><topic>Availability</topic><topic>Brain</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Carbon Radioisotopes</topic><topic>Case-Control Studies</topic><topic>Choice Behavior</topic><topic>Cocaine</topic><topic>Cocaine - administration & dosage</topic><topic>Cocaine Smoking</topic><topic>Cocaine-Related Disorders - diagnostic imaging</topic><topic>Cocaine-Related Disorders - metabolism</topic><topic>Cocaine-Related Disorders - psychology</topic><topic>Drug abuse</topic><topic>Drug self-administration</topic><topic>Drug therapy</topic><topic>Dynorphin</topic><topic>Dynorphins - metabolism</topic><topic>Emission analysis</topic><topic>Humans</topic><topic>Laboratories</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Naltrexone - pharmacology</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Narcotics</topic><topic>Neostriatum</topic><topic>Neostriatum - diagnostic imaging</topic><topic>Neostriatum - metabolism</topic><topic>Neuroimaging</topic><topic>Opioid receptors (type kappa)</topic><topic>Piperazines</topic><topic>Positron emission tomography</topic><topic>Pyrrolidines</topic><topic>Receptors, Opioid, kappa - metabolism</topic><topic>Stress</topic><topic>Stress, Psychological - psychology</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martinez, Diana</creatorcontrib><creatorcontrib>Slifstein, Mark</creatorcontrib><creatorcontrib>Matuskey, David</creatorcontrib><creatorcontrib>Nabulsi, Nabeel</creatorcontrib><creatorcontrib>Zheng, Ming-Qiang</creatorcontrib><creatorcontrib>Lin, Shu-Fei</creatorcontrib><creatorcontrib>Ropchan, Jim</creatorcontrib><creatorcontrib>Urban, Nina</creatorcontrib><creatorcontrib>Grassetti, Alexander</creatorcontrib><creatorcontrib>Chang, Dinnisa</creatorcontrib><creatorcontrib>Salling, Michael</creatorcontrib><creatorcontrib>Foltin, Richard</creatorcontrib><creatorcontrib>Carson, Richard E</creatorcontrib><creatorcontrib>Huang, Yiyun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinez, Diana</au><au>Slifstein, Mark</au><au>Matuskey, David</au><au>Nabulsi, Nabeel</au><au>Zheng, Ming-Qiang</au><au>Lin, Shu-Fei</au><au>Ropchan, Jim</au><au>Urban, Nina</au><au>Grassetti, Alexander</au><au>Chang, Dinnisa</au><au>Salling, Michael</au><au>Foltin, Richard</au><au>Carson, Richard E</au><au>Huang, Yiyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>44</volume><issue>10</issue><spage>1720</spage><epage>1727</epage><pages>1720-1727</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><abstract>Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [
C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [
C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [
C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [
C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>31026862</pmid><doi>10.1038/s41386-019-0398-4</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-133X |
ispartof | Neuropsychopharmacology (New York, N.Y.), 2019-09, Vol.44 (10), p.1720-1727 |
issn | 0893-133X 1740-634X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6785004 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
subjects | Addictions Adult Availability Brain Brain - diagnostic imaging Brain - metabolism Carbon Radioisotopes Case-Control Studies Choice Behavior Cocaine Cocaine - administration & dosage Cocaine Smoking Cocaine-Related Disorders - diagnostic imaging Cocaine-Related Disorders - metabolism Cocaine-Related Disorders - psychology Drug abuse Drug self-administration Drug therapy Dynorphin Dynorphins - metabolism Emission analysis Humans Laboratories Male Middle Aged Naltrexone - pharmacology Narcotic Antagonists - pharmacology Narcotics Neostriatum Neostriatum - diagnostic imaging Neostriatum - metabolism Neuroimaging Opioid receptors (type kappa) Piperazines Positron emission tomography Pyrrolidines Receptors, Opioid, kappa - metabolism Stress Stress, Psychological - psychology Tomography |
title | Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T05%3A08%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kappa-opioid%20receptors,%20dynorphin,%20and%20cocaine%20addiction:%20a%20positron%20emission%20tomography%20study&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Martinez,%20Diana&rft.date=2019-09-01&rft.volume=44&rft.issue=10&rft.spage=1720&rft.epage=1727&rft.pages=1720-1727&rft.issn=0893-133X&rft.eissn=1740-634X&rft_id=info:doi/10.1038/s41386-019-0398-4&rft_dat=%3Cproquest_pubme%3E2272719448%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2272719448&rft_id=info:pmid/31026862&rfr_iscdi=true |